Recruiting Pulmonary Embolism Studies in Stony Brook
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
Sodium zirconium cyclosilicate has been shown to be effective and safe in adults for the treatment of hyperkalaemia, and therefore it is expected to be beneficial in children. This study will evaluate...
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV
The primary objective of this study is to evaluate the dose effect of Phenylephrine Hydrochloride Injection on the treatment of clinically relevant decreased blood pressure in the pediatric population...
About Pulmonary Embolism Clinical Trials in Stony Brook
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Stony Brook, NY. These studies are seeking a combined 240 participants. Research is being sponsored by AstraZeneca, West-Ward Pharmaceutical. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Stony Brook — FAQ
Are there pulmonary embolism clinical trials in Stony Brook?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Stony Brook, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stony Brook?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stony Brook research site will contact you about next steps.
Are clinical trials in Stony Brook free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stony Brook studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Stony Brook are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov